Commonwealth Equity Services
AGN

Commonwealth Equity Services’s Allergan Inc AGN Stock Holding History

Commonwealth Equity Services’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,710
Closed -$2.28M – 2277
2014
Q4 		$2.28M Buy
10,710
+1,627
+18% +$324K 0.03% 523
2014
Q3 		$1.62M Sell
9,083
-441
-5% -$73.2K 0.02% 634
2014
Q2 		$1.61M Sell
9,524
-1,094
-10% -$170K 0.02% 637
2014
Q1 		$1.32M Buy
10,618
+34
+0.3% +$4.14K 0.02% 671
2013
Q4 		$1.18M Buy
10,584
+2,973
+39% +$284K 0.02% 683
2013
Q3 		$688K Buy
7,611
+575
+8% +$51.6K 0.01% 913
2013
Q2 		$593K Buy
+7,036
New +$730K 0.01% 947

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Commonwealth Equity Services's AGN Position: Q1 2015 in Review

Commonwealth Equity Services sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 10,710 shares — an estimated $2.28M sold.

Commonwealth Equity Services first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $2.28M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Commonwealth Equity Services reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Commonwealth Equity Services sold 10,710 Allergan Inc shares in Q1 2015, an estimated $2.28M.
  • Commonwealth Equity Services first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Commonwealth Equity Services's Allergan Inc position peaked at $2.28M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Commonwealth Equity Services's 13F filing for Q1 2015, filed 28 Apr 2015.